11
Journal Reading Journal Reading Thrombolysis in Ischemic Stroke Without Arterial Thrombolysis in Ischemic Stroke Without Arterial Occlusion at Presentation Occlusion at Presentation Presentated by: Presentated by: Idrus Alhamid Idrus Alhamid Rosario Rumaropen Rosario Rumaropen Desika A Wambrauw Desika A Wambrauw SMF Neuro RSUD Dok II FK UNCEN Jayapura Sourabh Lahoti, MD; Sankalp Gokhale, MD; Louis Caplan, MD; Sourabh Lahoti, MD; Sankalp Gokhale, MD; Louis Caplan, MD; Patrik Michel, MD; Yves Samson, MD; Charlotte Rosso, MD, PhD; Patrik Michel, MD; Yves Samson, MD; Charlotte Rosso, MD, PhD; Kaustubh Limaye, MD; Archana Hinduja, MD; Aneesh Singhal, MD; Kaustubh Limaye, MD; Archana Hinduja, MD; Aneesh Singhal, MD; Syed Ali, MD; Luther Creed Pettigrew, MD; Richard Kryscio, PhD; Syed Ali, MD; Luther Creed Pettigrew, MD; Richard Kryscio, PhD; Nikita Dedhia, MD; Shirish Hastak, MD, DM; David S. Liebeskind, Nikita Dedhia, MD; Shirish Hastak, MD, DM; David S. Liebeskind, MD MD

thrombolysis in ischemic stroke without arterial occlusion

Embed Size (px)

DESCRIPTION

Hope useful..

Citation preview

Page 1: thrombolysis in ischemic stroke without arterial occlusion

Journal ReadingJournal Reading

Thrombolysis in Ischemic Stroke Without Arterial Thrombolysis in Ischemic Stroke Without Arterial Occlusion at PresentationOcclusion at Presentation

Presentated by:Presentated by:Idrus AlhamidIdrus Alhamid

Rosario RumaropenRosario RumaropenDesika A WambrauwDesika A Wambrauw

SMF Neuro RSUD Dok II FK UNCEN Jayapura

Sourabh Lahoti, MD; Sankalp Gokhale, MD; Louis Caplan, MD; Patrik Sourabh Lahoti, MD; Sankalp Gokhale, MD; Louis Caplan, MD; Patrik Michel, MD; Yves Samson, MD; Charlotte Rosso, MD, PhD; Kaustubh Michel, MD; Yves Samson, MD; Charlotte Rosso, MD, PhD; Kaustubh

Limaye, MD; Archana Hinduja, MD; Aneesh Singhal, MD; Syed Ali, Limaye, MD; Archana Hinduja, MD; Aneesh Singhal, MD; Syed Ali, MD; Luther Creed Pettigrew, MD; Richard Kryscio, PhD; Nikita MD; Luther Creed Pettigrew, MD; Richard Kryscio, PhD; Nikita Dedhia, MD; Shirish Hastak, MD, DM; David S. Liebeskind, MDDedhia, MD; Shirish Hastak, MD, DM; David S. Liebeskind, MD

Page 2: thrombolysis in ischemic stroke without arterial occlusion

- None of the randomized trials of None of the randomized trials of intravenous tissue-type intravenous tissue-type plasminogen activator reportedplasminogen activator reported vascular imaging acquired before vascular imaging acquired before thrombolysisthrombolysis

- Efficacy of tissue-type Efficacy of tissue-type plasminogen activator in stroke plasminogen activator in stroke without arterial occlusion on without arterial occlusion on vascular imaging remains vascular imaging remains unknown and speculative.unknown and speculative.

Page 3: thrombolysis in ischemic stroke without arterial occlusion

r-tPA

Aktivasi plasminogen utk di konversi mjd plasmin Lisis trombosit

yg kaya fibrin

RekanalisasiArteri yg teroklusi &

tjd perbaikan aliran darah

Jika diberikan dlm 3-4,5 jam dr onset timbul gejala mcegah tjd infark jaringan perbaikan klinis

Page 4: thrombolysis in ischemic stroke without arterial occlusion
Page 5: thrombolysis in ischemic stroke without arterial occlusion

MethodsMethods

- RRetrospective, multicenter study to etrospective, multicenter study to collect data of patients who presented collect data of patients who presented to participating centers during a 5-year to participating centers during a 5-year period with ischemic stroke diagnosed period with ischemic stroke diagnosed by clinical examination and MRI and by clinical examination and MRI and with imaging evidence of no vascular with imaging evidence of no vascular occlusion. occlusion.

- DDivided into 2 groups: those who ivided into 2 groups: those who received thrombolytic therapy and received thrombolytic therapy and those who did not. those who did not.

Page 6: thrombolysis in ischemic stroke without arterial occlusion
Page 7: thrombolysis in ischemic stroke without arterial occlusion
Page 8: thrombolysis in ischemic stroke without arterial occlusion
Page 9: thrombolysis in ischemic stroke without arterial occlusion

ResultsResults A total of 256 patients met study criteria, A total of 256 patients met study criteria,

103 with thrombolysis and 153 without. 103 with thrombolysis and 153 without. Logistic regression analysis showed that Logistic regression analysis showed that

patients who received thrombolysis had patients who received thrombolysis had more frequent excellent outcomes with odds more frequent excellent outcomes with odds ratio of 3.79 (P<0.01). ratio of 3.79 (P<0.01).

Thrombolysis led to more frequent excellent Thrombolysis led to more frequent excellent outcome in nonlacunar group with odds outcome in nonlacunar group with odds ratio 4.90 (P<0.01) and more frequent ratio 4.90 (P<0.01) and more frequent perfect outcome in lacunar group with odds perfect outcome in lacunar group with odds ratio 8.25 (P<0.01)ratio 8.25 (P<0.01)

Page 10: thrombolysis in ischemic stroke without arterial occlusion

ConclusionConclusion In conclusion, this retrospective study In conclusion, this retrospective study

demonstrates the efficacy of intravenous demonstrates the efficacy of intravenous thrombolysis in patients with ischemic stroke thrombolysis in patients with ischemic stroke who have no radiographically demonstrated who have no radiographically demonstrated arterial occlusion at presentation. arterial occlusion at presentation.

Both subgroups, nonlacunar and lacunar strokes, Both subgroups, nonlacunar and lacunar strokes, were found to have had better clinical outcome were found to have had better clinical outcome after receiving r-tPA. after receiving r-tPA.

A prospective study to validate these results is A prospective study to validate these results is needed and is being plannedneeded and is being planned

Page 11: thrombolysis in ischemic stroke without arterial occlusion